By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Announces Closing Of Initial Public Offering 10/8/2015 11:55:57 AM
NovoCure Release: FDA Approves Optune In Combination With Temozolomide For The Treatment Of Newly Diagnosed Glioblastoma 10/6/2015 11:59:16 AM
NovoCure Grabs CE Mark and First Patient Use of Second Generation Optune System 10/5/2015 6:54:20 AM
NovoCure Prices $165 Million IPO 10/2/2015 7:19:17 AM
NovoCure Sets Terms for $344 Million IPO 9/21/2015 7:41:19 AM
NovoCure To Present The Latest Data From The EF-14 Clinical Trial In Newly Diagnosed GBM At The 15th Interim Meeting Of The World Federation Of Neurosurgical Societies 9/9/2015 10:48:29 AM
NovoCure Announces Optune Now Available At More Than 200 Leading Cancer Centers Across The United States 9/8/2015 11:30:39 AM
NovoCure Preps for $300 Million IPO 9/2/2015 7:01:17 AM
NovoCure Ltd. Release: Data On Tumor Treating Fields To Be Presented At The 37th Annual Conference Of The IEEE Engineering In Medicine And Biology Society 8/26/2015 8:40:37 AM
NovoCure Ltd. Selected As Technology Pioneer By World Economic Forum 8/5/2015 11:27:42 AM